Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer
Nakashima, Kazuhisa, Akamatsu, Hiroaki, Murakami, Haruyasu, Niwa, Takashi, Iwamoto, Yasuo, Ozawa, Yuichi, Yokoyama, Toshihide, Shoda, Hiroyasu, Yamamoto, Nobuyuki, Yoshioka, Hiroshige, Masuda, Ken, Naito, Tateaki, Mori, Keita, Takahashi, Toshiaki
Published in Anticancer research (01.03.2019)
Published in Anticancer research (01.03.2019)
Get full text
Journal Article
Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan
Nokihara, Hiroshi, Kijima, Takashi, Yokoyama, Toshihide, Kagamu, Hiroshi, Suzuki, Takuji, Mori, Masahide, Santorelli, Melissa L, Taniguchi, Kazuko, Kamitani, Tetsu, Irisawa, Masato, Kanda, Kingo, Abe, Machiko, Burke, Thomas, Goto, Yasushi
Published in Cancers (09.06.2022)
Published in Cancers (09.06.2022)
Get full text
Journal Article
The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study
Nishimura, Tomoka, Ichihara, Eiki, Yokoyama, Toshihide, Inoue, Koji, Tamura, Tomoki, Sato, Ken, Oda, Naohiro, Kano, Hirohisa, Kishino, Daizo, Kawai, Haruyuki, Inoue, Masaaki, Ochi, Nobuaki, Fujimoto, Nobukazu, Ichikawa, Hirohisa, Ando, Chihiro, Hotta, Katsuyuki, Maeda, Yoshinobu, Kiura, Katsuyuki
Published in Cancers (14.12.2022)
Published in Cancers (14.12.2022)
Get full text
Journal Article
The impact of sequential therapy of crizotinib followed by alectinib: Real-world data analysis of 840 ALK-inhibitor naïve patients with NSCLC harboring ALK-rearrangement (WJOG9516L)
Ito, Kentaro, Yamanaka, Takeharu, Watanabe, Satomi, Hattori, Yoshihiro, Nishino, Kazumi, Kobayashi, Haruki, Oya, Yuko, Yokoyama, Toshihide, Seto, Takashi, Azuma, Koichi, Fukui, Tomoya, Kozuki, Toshiyuki, Nakamura, Atsushi, Okamoto, Isamu, Hirano, Katsuya, Yokoi, Takashi, Daga, Haruko, Sakata, Shinya, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302
Ikeda, Satoshi, Yoshioka, Hiroshige, Kaneda, Toshihiko, Yokoyama, Toshihide, Niwa, Takashi, Sone, Naoyuki, Ishida, Tadashi, Morita, Mitsunori, Tomioka, Hiromi, Komaki, Chihito, Hirabayashi, Masataka, Hasegawa, Yoshinori, Noguchi, Tetsuo, Nakano, Yasutaka, Sakaguchi, Chikara, Yoshimura, Kenichi, Hirai, Toyohiro
Published in Oncology (01.12.2019)
Published in Oncology (01.12.2019)
Get more information
Journal Article
Afatinib (Afa) plus bevacizumab (Bev) combination after acquired resistance (AR) to EGFR-tyrosine kinase inhibitors (TKIs) in EGFR -mutant non-small cell lung cancer (NSCLC): Multicenter single arm phase II trial (ABC-study)
Hata, Akito, Katakami, Nobuyuki, Kaji, Reiko, Yokoyama, Toshihide, Kaneda, Toshihiko, Tamiya, Motohiro, Inoue, Takako, Kimura, Hiromi, Yano, Yukihiro, Tamura, Daisuke, Morita, Satoshi, Negoro, Shunichi
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase II study of osimertinib in patients with plasma EGFR T790M positive advanced lung cancer (WJOG8815L/LPS)
Takahama, Takayuki, Azuma, Koichi, Shimokawa, Mototsugu, Kato, Terufumi, Daga, Haruko, Okamoto, Isamu, Akamatsu, Hiroaki, Takahashi, Toshiaki, Ohira, Tatsuo, Yokoyama, Toshihide, Hirano, Katsuya, Shiraishi, Yoshimasa, Himeji, Daisuke, Yamamoto, Nobuyuki, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
SPS-4Phase II study of osimertinib in patients with plasma EGFR T790M positive advanced lung cancer (WJOG8815L/LPS)
Takahama, Takayuki, Azuma, Koichi, Shimokawa, Mototsugu, Kato, Terufumi, Daga, Haruko, Okamoto, Isamu, Akamatsu, Hiroaki, Takahashi, Toshiaki, Ohira, Tatsuo, Yokoyama, Toshihide, Hirano, Katsuya, Shiraishi, Yoshimasa, Himeji, Daisuke, Yamamoto, Nobuyuki, Nishio, Kazuto, Nakagawa, Kazuhiko
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase II study of first-line low-dose afatinib in patients with EGFR mutated non-small-cell lung cancer (KTORG1402)
Okuno, Takehiro, Yokoyama, Toshihide, Yoshioka, Hiroshige, Fujimoto, Daichi, Hirano, Katsuya, Kawai, Takahiro, Kagami, Ryogo, Ishida, Tadashi, Tomii, Keisuke, Demura, Yoshiki, Hirabayashi, Masataka, Nishimura, Takashi, Nakahara, Yasuharu, Hak Kim, Young, Yoshimura, Kenichi, Hirai, Toyohiro
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
O2-10-1A phase II study of first-line low-dose afatinib in patients with EGFR mutated non-small-cell lung cancer (KTORG1402)
Okuno, Takehiro, Yokoyama, Toshihide, Yoshioka, Hiroshige, Fujimoto, Daichi, Hirano, Katsuya, Kawai, Takahiro, Kagami, Ryogo, Ishida, Tadashi, Tomii, Keisuke, Demura, Yoshiki, Hirabayashi, Masataka, Nishimura, Takashi, Nakahara, Yasuharu, Hak Kim, Young, Yoshimura, Kenichi, Hirai, Toyohiro
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer
Sakamoto, Tomohiro, Matsubara, Taichi, Takahama, Takayuki, Yokoyama, Toshihide, Nakamura, Atsushi, Tokito, Takaaki, Okamoto, Tatsuro, Akamatsu, Hiroaki, Oki, Masahide, Sato, Yuki, Tobino, Kazunori, Ikeda, Satoshi, Mori, Masahide, Mimura, Chihiro, Maeno, Ken, Miura, Satoru, Harada, Toshiyuki, Nishimura, Kunihiro, Hiraoka, Manabu, Kenmotsu, Hirotsugu, Fujimoto, Junya, Shimokawa, Mototsugu, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Published in JAMA network open (01.12.2023)
Published in JAMA network open (01.12.2023)
Get full text
Journal Article
Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study
Ikeda, Satoshi, Arita, Machiko, Misaki, Kenta, Mishima, Shohei, Takaiwa, Takuya, Nishiyama, Akihiro, Ito, Akihiro, Furuta, Kenjiro, Yokoyama, Toshihide, Tokioka, Fumiaki, Noyama, Maki, Yoshioka, Hiroshige, Ishida, Tadashi
Published in SpringerPlus (28.05.2015)
Published in SpringerPlus (28.05.2015)
Get full text
Journal Article
Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol
Ninomiya, Takashi, Ishikawa, Nobuhisa, Inoue, Koji, Kubo, Toshio, Yasugi, Masayuki, Shibayama, Takuo, Maeda, Tadashi, Fujitaka, Kazunori, Kodani, Masahiro, Yokoyama, Toshihide, Kuyama, Shoichi, Ochi, Nobuaki, Ueda, Yutaka, Miyoshi, Seigo, Kozuki, Toshiyuki, Amano, Yoshihiro, Kubota, Tetsuya, Sugimoto, Keisuke, Bessho, Akihiro, Ishii, Tomoya, Watanabe, Kazuhiko, Oze, Isao, Hotta, Katsuyuki, Kiura, Katsuyuki
Published in Clinical lung cancer (01.03.2019)
Published in Clinical lung cancer (01.03.2019)
Get full text
Journal Article
Inhibitory effect of the selective serotonin 5-HT3 receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats
Nakata-Fukuda, Mari, Hirata, Takuya, Keto, Yoshihiro, Yamano, Mayumi, Yokoyama, Toshihide, Uchiyama, Yasuo
Published in European journal of pharmacology (15.05.2014)
Published in European journal of pharmacology (15.05.2014)
Get full text
Journal Article
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility
Fujimoto, Daichi, Morimoto, Takeshi, Tamiya, Motohiro, Hata, Akito, Matsumoto, Hirotaka, Nakamura, Atsushi, Yokoyama, Toshihide, Taniguchi, Yoshihiko, Uchida, Junji, Sato, Yuki, Yokoi, Takashi, Tanaka, Hisashi, Furuya, Naoki, Masuda, Takeshi, Sakata, Yoshihiko, Miyauchi, Eisaku, Hara, Satoshi, Saito, Go, Miura, Satoru, Kanazu, Masaki, Yamamoto, Nobuyuki, Akamatsu, Hiroaki
Published in JAMA network open (01.02.2023)
Published in JAMA network open (01.02.2023)
Get full text
Journal Article
Inhibitory effect of the selective serotonin 5-HT sub(3) receptor antagonist ramosetron on duodenal acidification-induced gastric hypersensitivity in rats
Nakata-Fukuda, Mari, Hirata, Takuya, Keto, Yoshihiro, Yamano, Mayumi, Yokoyama, Toshihide, Uchiyama, Yasuo
Published in European journal of pharmacology (01.05.2014)
Published in European journal of pharmacology (01.05.2014)
Get full text
Journal Article
P3.02a-005 The Association between the Percentage of Anaplastic Lymphoma Kinase(ALK)-Positive Cells and Efficacy of ALK Inhibitor: Topic: ALK Biomarkers
Tanaka, Tae, Yoshioka, Hiroshige, Haratani, Koji, Hayashi, Hidetoshi, Okamoto, Kunio, Kaneda, Toshihiko, Yokoyama, Toshihide, Takeda, Masayuki, Kaneda, Hiroyasu, Nakagawa, Kazuhiko, Ishida, Tadashi
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article
P3.02a-005 The Association between the Percentage of Anaplastic Lymphoma Kinase(ALK)-Positive Cells and Efficacy of ALK Inhibitor
Tanaka, Tae, Yoshioka, Hiroshige, Haratani, Koji, Hayashi, Hidetoshi, Okamoto, Kunio, Kaneda, Toshihiko, Yokoyama, Toshihide, Takeda, Masayuki, Kaneda, Hiroyasu, Nakagawa, Kazuhiko, Ishida, Tadashi
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article
Phase II Study of the EGFR-TKI Rechallenge With Afatinib in Patients With Advanced NSCLC Harboring Sensitive EGFR Mutation Without T790M: Okayama Lung Cancer Study Group Trial OLCSG 1403
Oda, Naohiro, Ichihara, Eiki, Hotta, Katsuyuki, Ninomiya, Kiichiro, Ninomiya, Takashi, Kubo, Toshio, Minami, Daisuke, Murakami, Toshi, Yokoyama, Toshihide, Harada, Daijiro, Kuyama, Shoichi, Ichikawa, Hirohisa, Inoue, Koji, Kishino, Daizo, Inoue, Masaaki, Takigawa, Nagio, Shibayama, Takuo, Harita, Shingo, Tanimoto, Mitsune, Kiura, Katsuyuki
Published in Clinical lung cancer (01.03.2017)
Published in Clinical lung cancer (01.03.2017)
Get full text
Journal Article